Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.
Cystic fibrosis (CF), which is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), is characterized by multiorgan pathology that begins early in life. To better understand the initial stages of disease, we studied the gastrointestinal pathology of CFTR-/- pigs. By studying newborns, we avoided secondary changes attributable to environmental interactions, infection, or disease progression. Lesions resembling those in humans with CF were detected in intestine, pancreas, liver, gallbladder, and cystic duct. These organs had four common features. First, disease was accelerated compared with that in humans, which could provide a strategy to discover modifying factors. Second, affected organs showed variable hyperplastic, metaplastic, and connective tissue changes, indicating that remodeling was a dynamic component of fetal life. Third, cellular inflammation was often mild to moderate and not always present, which raises new questions as to the role of cellular inflammation in early disease pathogenesis. Fourth, epithelial mucus-producing cells were often increased, producing a striking accumulation of mucus with a layered appearance and resilient structure. Thus, mucus cell hyperplasia and mucus accumulation play prominent roles in early disease. Our findings also have implications for CF lung disease, and they lay the foundation for a better understanding of CF pathogenesis.
Meyerholz
David K
DK
Department of Pathology, Howard Hughes Medical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. david-meyerholz@uiowa.edu
Stoltz
David A
DA
Pezzulo
Alejandro A
AA
Welsh
Michael J
MJ
D000818:Animals; D049109:Cell Proliferation; D003550:Cystic Fibrosis / Q000473:pathology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000172:deficiency / Q000378:metabolism; D004195:Disease Models, Animal; D005704:Gallbladder / Q000473:pathology; D041981:Gastrointestinal Tract / Q000473:pathology*; D007249:Inflammation / Q000473:pathology; D007422:Intestines / Q000473:pathology; D008099:Liver / Q000473:pathology; D009093:Mucus / Q000378:metabolism; D009130:Muscle, Smooth / Q000473:pathology; D009928:Organ Specificity; D010179:Pancreas / Q000473:pathology; D034421:Sus scrofa
D019005:Cystic Fibrosis Transmembrane Conductance Regulator